Last checked at 5 Mar 2018 07:00
ECO Animal Health Group plc
(AIM: EAH)
ARGENTINA GRANTS ECO MARKETING AUTHORISATIONS FOR AIVLOSIN® FOR PIGS AND POULTRY
ECO Animal Health Group plc is pleased to announce that its subsidiary ECO Argentina S.A (ECO) has received a number of marketing authorisations for Aivlosin® from the Competent Authority SENASA (Servicio Nacional de Sanidad y Calidad Agroalimentaria) in the Republic of Argentina.
Aivlosin®,ECO’s patented antimicrobial, is used for the treatment of a variety of economically important respiratory and enteric (gut) diseases in pigs and poultry.
These authorisations, which are for the use of Aivlosin® 625 mg/g water soluble granules for both pigs and poultry, allow ECO to start selling Aivlosin® in the Republic of Argentina for the medication of drinking water for the treatment of infections caused by Mycoplasma in poultry laying eggs for human consumption, with a zero day drug withdrawal period for eggs.
These new treatments meet all the latest guidelines for the responsible use of antimicrobials. Importantly, with global concerns about the use of antibiotics in food production animals, Aivlosin® is administered under the control of veterinarians, available by prescription only and has low, highly effective therapeutic dose rates, a short treatment duration and a zero day drug withholding period.
Peter Lawrence, Chairman of ECO, commented “We are extremely pleased to receive these marketing authorisations for Aivlosin® in Argentina, the third largest egg and second largest pork producing country in South America.”
The information contained within this announcement is deemed by the Group to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014 ("MAR"). Upon the publication of this announcement via a Regulatory Information Service ("RIS"), this inside information is now considered to be in the public domain.
Contacts:
ECO Animal Health Group plc
| Peter Lawrence | 020 8336 6190 | |
| Marc Loomes | 020 8447 6906 | |
| Spiro Financial | ||
| Anthony Spiro | 020 8336 6196 | |
| N+1 Singer (Nominated Adviser) | 020 7496 3000 | |
| Mark Taylor, Brough Ransom | ||
| Peel Hunt LLP (Joint Broker) | ||
| James Steel, Dr Christopher Golden | 020 7418 8900 |
View source version on businesswire.com: http://www.businesswire.com/news/home/20180304005011/en/
Copyright Business Wire 2018